Free Trial
OTCMKTS:GRRMF

Gerresheimer (GRRMF) Stock Price, News & Analysis

Gerresheimer logo
$64.07 0.00 (0.00%)
As of 05/7/2025

About Gerresheimer Stock (OTCMKTS:GRRMF)

Key Stats

Today's Range
$64.07
$64.07
50-Day Range
$64.07
$91.72
52-Week Range
$64.07
$114.50
Volume
N/A
Average Volume
956 shs
Market Capitalization
N/A
P/E Ratio
28.22
Dividend Yield
0.81%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Receive GRRMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

GRRMF Stock News Headlines

Gerresheimer price target lowered to EUR 95 from EUR 110 at Berenberg
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
Q1 2025 Gerresheimer AG Earnings Call Transcript
Gerresheimer Aktie: Zukauf kaschiert Schwäche
See More Headlines

GRRMF Stock Analysis - Frequently Asked Questions

Gerresheimer's stock was trading at $69.75 at the beginning of 2025. Since then, GRRMF shares have decreased by 8.1% and is now trading at $64.07.
View the best growth stocks for 2025 here
.

Shares of GRRMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/08/2025
Next Earnings (Estimated)
7/09/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:GRRMF
CIK
N/A
Fax
N/A
Employees
11,947
Year Founded
N/A

Profitability

Trailing P/E Ratio
28.22
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:GRRMF) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners